Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;36(2):327-347.
doi: 10.1016/j.idc.2022.02.002.

Laboratory Diagnosis for SARS-CoV-2 Infection

Affiliations
Review

Laboratory Diagnosis for SARS-CoV-2 Infection

Bianca B Christensen et al. Infect Dis Clin North Am. 2022 Jun.

Abstract

The optimal diagnostic test for SARS-CoV-2 infection should be selected based on a patient's clinical syndrome and presentation in relation to symptom onset. Molecular testing, most often reverse-transcriptase polymerase chain reaction, offers the highest sensitivity and specificity during acute infection, whereas antigen testing can also be useful for acute diagnosis when rapid turnaround of results is necessary or if molecular testing is unavailable. Serologic testing is often reserved for identifying individuals with prior or late COVID-19 infection.

Keywords: Antigen testing; COVID-19; Nucleic acid amplification testing; SARS-CoV-2 diagnostics; Serology.

PubMed Disclaimer

Conflict of interest statement

Disclosure S.E. Turbett receives grant support from the Centers for Disease Control and Prevention for COVID-19-related work. She also receives royalties from UpToDate. The remaining authors have nothing to disclose.

Figures

Fig. 1
Fig. 1
Timing of virological and immunologic biomarkers during COVID-19 infection.
Fig. 2
Fig. 2
SARS-CoV-2 genome.
Fig. 3
Fig. 3
SARS-CoV-2 structure.
Fig. 4
Fig. 4
RT-PCR.

Similar articles

Cited by

References

    1. van den Borst B., Peters J.B., Brink M., et al. comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19) Clin Infect Dis. 2021;73(5):e1089. - PMC - PubMed
    1. Wang Q.J., Yao Y.Z., Song J.S., et al. Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study. BMC Infect Dis. 2020;20(1):818. - PMC - PubMed
    1. Nussenblatt V., Roder A.E., Das S., et al. Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B cell depletion. medRxiv. 2021 doi: 10.1101/2021.10.02.21264267. Published online October 5, 2021. - DOI - PMC - PubMed
    1. Choi B., Choudhary M.C., Regan J., et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med. 2020;383(23):2291–2293. - PMC - PubMed
    1. Greninger AL, Dien Bard J, Colgrove RC, et al. Clinical and infection prevention applications of SARS-CoV-2 genotyping: an IDSA/ASM consensus review document. Clin Infect Dis. Published online November 3, 2021. doi:10.1093/cid/ciab761

Publication types